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Abstract Maturation or M phase-promoting factor (MPF) is
the universal inducer of M phase common to eukaryotic cells.
MPF was originally defined as a transferable activity that can
induce the G2/M phase transition in recipient cells. Today,
however, MPF is assumed to describe an activity that exhibits
its effect in donor cells, and furthermore, MPF is consistently
equated with the kinase cyclin B-Cdk1. In some conditions,
however, MPF, as originally defined, is undetectable even
though cyclin B-Cdk1 is fully active. For over three decades,
this inconsistency has remained a long-standing puzzle. The
enigma is now resolved through the elucidation that MPF,
defined as an activity that exhibits its effect in recipient cells,
consists of at least two separate kinases, cyclin B-Cdk1 and
Greatwall (Gwl). Involvement of Gwl in MPF can be ex-
plained by its contribution to the autoregulatory activation of
cyclin B-Cdk1 and by its stabilization of phosphorylations on
cyclin B-Cdk1 substrates, both of which are essential when
MPF induces the G2/M phase transition in recipient cells. To
accomplish these tasks, Gwl helps cyclin B-Cdk1 by sup-
pressing protein phosphatase 2A (PP2A)-B55 that counteracts
cyclin B-Cdk1. MPF, as originally defined, is thus not synon-
ymous with cyclin B-Cdk1, but is instead a system consisting
of both cyclin B-Cdk1 that directs mitotic entry and Gwl that
suppresses the anti-cyclin B-Cdk1 phosphatase. The current
view that MPF is a synonym for cyclin B-Cdk1 in donor cells
is thus imprecise; instead, MPF is best regarded as the entire
pathway involved in the autoregulatory activation of cyclin B-
Cdk1, with specifics depending on the experimental system.
Keywords Arpp19/Ensa . Cyclin B-Cdk1 . Greatwall
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Introduction
Today, the term maturation or M phase-promoting factor
(MPF) is assumed simply to describe a molecule or molecular
complex that triggers M phase within the eukaryotic cell.
Originally, however, MPF was defined as a transferable activ-
ity that is not only present in the donor M phase cell but that
also can induce the G2/M phase transition in the recipient G2
phase cell in the absence of new protein synthesis. MPF, des-
ignated Bmaturation-promoting factor^, was first demonstrat-
ed over four decades ago byMasui andMarkert (1971) during
investigations on oocytes and eggs of the frog Rana pipiens.
Immature oocytes generally arrest their cell cycle at prophase
of the first meiosis. Release from this arrest, which is equiva-
lent to the G2/M phase transition in somatic cells, produces
mature, fertilizable haploid eggs. Masui and Markert found a
cytoplasmic activity they called MPF that is present in
donor maturing (equivalent toM phase) oocytes and that upon
transfer induces maturation (the G2/M phase transition) in
recipient immature oocytes (Fig. 1; the classical microinjec-
tion assay of MPF).
Roughly 20 years later, the results of three separate studies
on MPF, cell division cycle (cdc) mutants in yeasts, and
cyclins in marine invertebrates suddenly converged to support
the idea that MPF is the cyclin B-Cdc2 complex (reviewed by
Dunphy and Newport 1988; Hunt 1989; Nurse 1990). This
surprising finding enabled the BBig Bang^ of highly fruitful
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cell cycle research during the last decade of the 20th century
(during which time Cdc2 was renamed Cdk1; see Pines and
Hunter 1991a; Nigg 2001). So it is not surprising that the
current literature assumes that MPF is completely synony-
mous with cyclin B-Cdc2/Cdk1.
Nonetheless, previous studies never precisely clarified
whether cyclin B-Cdk1 is, in fact, sufficient for MPF. Indeed,
certain conditions have long been known in which cyclin B-
Cdk1 is activated but MPF is undetectable (Kishimoto et al.
1981; Picard et al. 1988). This article will review the major gap
between MPF and cyclin B-Cdk1 that exists in the historical
literature and will solve this riddle by introducing another play-
er called Greatwall kinase (Gwl; Yu et al. 2004).
A brief history of MPF
Soon after the discovery of frog MPF (Masui and Markert
1971; Smith and Ecker 1971), similar transferable cytoplamic
activity was detected in the maturing oocytes of starfish
(Kishimoto and Kanatani 1976), mouse (Kishimoto et al.
1984; Sorensen et al. 1985), and other animals such as surf
clam (Kishimoto et al. 1984; reviewed in Kishimoto 1988).
This cytoplasmic activity was cross-reactive among different
species; for example, frog MPF could induce maturation in
recipient starfish oocytes (Kishimoto et al. 1982). The idea
thus emerged that MPF activity is not restricted to frog oo-
cytes alone (reviewed in Kishimoto 1988, 1996).
The general importance of MPF was further established by
demonstrations that mitotically dividing cells have an equiv-
alent activity. These MPF sources included, first, the
cytoplasm of cleaving blastomeres of frog (Wasserman and
Smith 1978; Gerhart et al. 1984) and starfish (Kishimoto
et al. 1982); second, crude extracts from HeLa or other mam-
malian somatic cells synchronized at M phase (Sunkara et al.
1979; Kishimoto et al. 1982); and third, crude extracts from
cdc mutants of the yeast Saccharomyces cerevisiae that were
arrested in M phase by growth at the restrictive temperature
(Weintraub et al. 1982; Tachibana et al. 1987). In every case,
MPF activity was detected by microinjection into immature
oocytes of frog or starfish. Furthermore, embryos of the frog
Xenopus laevis that had been arrested in a G2 phase-like state
by inhibition of protein synthesis underwent nuclear envelope
breakdown (NEBD; a marker for M phase entry) following
injection with partially purified Xenopus MPF (Miake-Lye
et al. 1983). Although, to my knowledge, no report exists that
uses somatic cells as recipients of MPF injection, experiments
that were performed much earlier involving the fusion of
mammalian somatic cells at different cell cycle phases
(Johnson and Rao 1970) imply the presence of an activity
equivalent to MPF. By the early 1980s, maturation-
promoting factor (MPF) was thus envisioned to be the univer-
sal inducer of M phase in eukaryotic cells, and it was renamed
M phase-promoting factor with the same abbreviation
(Gerhart et al. 1985).
Beginning with Wasserman and Masui (1976) and continuing
for more than a decade, many researchers tried to purify MPF, but
all such attempts were unsuccessful (e.g., Wu and Gerhart 1980;
Adlakha et al. 1985; Kishimoto and Kondo 1986). Finally, Maller
and colleagues succeeded in purifying MPF biochemically from
frog Xenopus laevis mature eggs by combining conventional col-
umn chromatographies with an assay system that employed cell-
free egg extracts (Lohka et al. 1988). Purified frogMPF contained
two major peptides of 32 and 45 kDa, and the purified preparation
was associated with histone H1 kinase activity. This finding con-
verged with great achievements in two separate fields, investiga-
tions on cell division cycle (cdc) mutants in yeasts and on cyclin
proteins in marine invertebrates eggs, yielding the conclusion less
than 2 years that MPF consists of the cyclin B-Cdc2 complex, a
kinase that is typically measured by its ability to phosphorylate
histone H1 (see Dunphy et al. 1988; Draetta et al. 1989; Labbe
et al. 1989; Gautier et al. 1988, 1990 as representatives of many
outstanding papers that led to this critical convergence of ideas;
reviewedbyDunphy andNewport 1988;Hunt 1989;Nurse 1990).
An enigma: based on the classical microinjection assay,
MPF is not identical to cyclin B-Cdk1
Certain early observations of starfish oocytes reported in the
literature (Kishimoto et al. 1981; Picard and Doree 1984) were
difficult to reconcile with the newly emerging view that MPF
and cyclin B-Cdc2/Cdk1 were exactly the same thing. In par-
ticular, it was found that MPF is almost undetectable by
Fig. 1 The identification of MPF through the classical microinjection
assay. Maturation-promoting factor (MPF) was originally defined as a
cytoplasmic activity transferable from mature (M phase) oocytes to im-
mature (G2/M phase border) oocytes. MPF is present in donor oocytes at
M phase, but its activity can be verified only when injected donor cyto-
plasm induces recipient oocytes arrested at G2 phase to transit into M
phase
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cytoplasmic transfer from enucleated donor oocytes of star-
fish, but MPF is restored by adding back a Bnuclear factor^
from the germinal vesicle (GV; i.e., contents from the oocyte
nucleus; see Fig. 2a; Kishimoto et al. 1981). However, cyclin
B-Cdk1 is activated in enucleated donor oocytes both in terms
of timing and of levels comparable to those in nucleated donor
oocytes (Picard et al. 1988; see also Fig. 1 in Hara et al. 2012).
These early observations clearly indicated that in the starfish
oocyte system, MPF is not simply identical to cyclin B-Cdk1,
but instead consists of both cyclin B-Cdk1 (found mostly in
the cytoplasm; see Ookata et al. 1992) and the unknown
nuclear factor (for reviews, see Kishimoto 1999; Doree and
Hunt 2002).
These results with starfish contrasted markedly with find-
ings in frog oocytes showing that MPF activity is unaffected
by the presence or absence of nuclei (Masui and Markert
1971; Reynhout and Smith 1974). A likely explanation for
the contrasting observations is that the starfish nuclear factor
is located in the cytoplasm in the oocytes of certain frog spe-
cies (see below; Hara et al. 2012).
Another discrepancy in the view that MPF=cyclin B-Cdk1




































































Fig. 2 MPF is not synonymous
with cyclin B-Cdk1. a Nuclear
contents are required for MPF. In
the starfish system, MPF is not
detectable from enucleated donor
oocytes, even those in which
cyclin B-Cdk1 is activated at
normal levels. But MPF is re-
stored when nuclear contents are
added back to donor enucleated
oocytes. 1-Methyladenine (1-
MeAde) is a starfish maturation-
inducing hormone, which acts
externally on immature oocytes to
cause the G2/M phase transition.
b Greatwall kinase (Gwl) is es-
sential for MPF. When Gwl ac-
tivity is suppressed in donor oo-
cytes by injection of neutralizing
antibodies, MPF is undetectable
even though cyclin B-Cdk1 be-
comes fully activated. Converse-
ly, Gwl restores MPF in enucle-
ated oocytes. c One order of
magnitude higher levels of Cdk1
activity are required for induction
of NEBD in the microinjection
assay, when purified cyclin B-
Cdk1 is compared with cyclin B-
Cdk1 contained in cytoplasmic
MPF. rGwl indicates recombi-
nant, active Gwl. d Addition of
Gwl to purified cyclin B-Cdk1
reduces the level of Cdk1 activity
required for NEBD to an amount
close to that contained in cyto-
plasmic MPF
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activity of purified cyclin B-Cdk1. Recall that MPF was for-
mally defined by microinjection into immature oocytes in
which its effect is verified (Fig. 1). Does purified cyclin B-
Cdk1 has the same level of MPF activity in this Bmicroinjection
assay^ as does donor oocyte cytoplasm contain an equivalent
level of Cdk1 activity? Surprisingly, the answer was BNO^
(Hara et al. 2012). In fact, purified cyclin B-Cdk1 failed to
induce the G2/M phase transition in recipient oocytes of star-
fish, unless approximately ten-fold more activity of purified
cyclin B-Cdk1 was injected than the Cdk1 activity present in
the least amount of donor cytoplasm that could induce the G2/
M phase transition (Okumura et al. 1996; see also Fig. 1 in Hara
et al. 2012; Fig. 2c). When injected below the threshold
amounts, cyclin B-Cdk1 is rapidly inactivated in the recipient
starfish oocytes (Picard et al. 1991; Okumura et al. 1996). It has
recently been shown that the same gap in the levels of cyclin B-
Cdk1 activity required for the G2/M phase transition exists
between purified kinase and donor cytoplasm in investigations
of frog oocytes (Hara et al. 2012).
Thus, in addition to cyclin B-Cdk1, MPF most likely con-
tains one or more additional components that antagonize the
inactivation of this kinase. An intriguing possibility is that this
antagonizing activity is carried by the nuclear factor in starfish
oocytes (see below).
MPF amplification
In retrospect, the first frog MPF article by Masui and Markert
(1971) contained an important clue for a possible role of the
nuclear factor. The authors found that MPF has an autocata-
lytic property called Bamplification,^ based on the observation
that the MPF activity contained in the cytoplasm does not
decrease through multiple successive transfers into immature
oocytes (Fig. 3). Such MPF amplification was observed in
starfish oocytes as well (Kishimoto and Kanatani 1976). The
amplification of MPF occurs normally even when protein
synthesis is suppressed in the oocytes of frog (Wasserman
and Masui 1975) and starfish (Doree 1982). These observa-
tions taken together suggest that a precursor ofMPF (preMPF)
is present in immature oocytes and can be transformed into
MPF through the action of MPF itself. Accordingly, the pro-
cess of MPF production in oocytes can be divided into two
steps (Fig. 4a). First, some kind of Binitiator^—a signal inde-
pendent of MPF—allows the production of a small amount of
MPF (i.e., Bprimary MPF^) from preMPF. Thereafter, the
autoregulatory amplification process allows the production
from preMPF of large amounts of MPF (Bamplified MPF^);
this amplification depends on MPF itself. During the micro-
injection assays described above, the MPF introduced into
recipient oocytes functions as the primary MPF; it starts the
MPF amplification loop in recipient oocytes despite the ab-
sence of the initiator.
Is the nuclear factor involved in the production of primary
MPF or in the production of amplified MPF? If the first recip-
ient oocytes have been enucleated in the serial transfer exper-
iment using starfish oocytes (Fig. 3), no NEBD occurs in the
second recipient oocytes (Kishimoto et al. 1981), even though
cyclin B-Cdk1 is fully activated in the enucleated first recip-
ient oocytes (Picard et al. 1991). These observations indicate
that the nuclear factor of donor oocytes is required for the
MPF amplification in recipient oocytes. A likely explanation
for this requirement is that in the absence of the nuclear factor,
small amounts of primary MPF in the recipient are inactivated
before they can initiate the amplification process.
Two-step activation of cyclin B-Cdk1
After the cyclin B-Cdk1 complex is first formed, its activity is
directly regulated negatively by Wee1/Myt1 kinase that phos-
phorylates Cdk1 for inhibition and positively by Cdc25 phos-
phatase that dephosphorylates the Wee1/Myt1 sites for activa-
tion (for review, see Lew and Kornbluth 1996; Fig. 4b). At the
G2/M phase border, all of the cyclin B-Cdk1 complex, Wee1/
Myt1 and Cdc25 proteins are already present, but cyclin B-
Cdk1 is kept inactive, implying that the balance of activity
between Wee1/Myt1 kinase and Cdc25 phosphatase is in-
clined to the inhibitory phosphorylation of Cdk1.
Fig. 3 Amplification of MPF. Even after serial cytoplasmic transfer,
MPF does not decrease, implying that MPF is autoactivated
(Bamplified^) in recipient oocytes. In the starfish system, approximately
1/15 volume of oocyte cytoplasm is transferred in each microinjection,
and hence, the original MPF is diluted approximately 50,000× in the
fourth recipient oocytes
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At the onset of M phase, the balance between Wee1/Myt1
and Cdc25 is first reversed by cyclin B-Cdk1-independent,
upstream signaling (the putative Binitial activator^), resulting
in a small population of active cyclin B-Cdk1. Subsequently, a
much larger population of cyclin B-Cdk1 becomes activated
through an autoregulatory loop in which active cyclin B-Cdk1
further inactivates Wee1/Myt1 and activates Cdc25 (for re-
views, see Lew and Kornbluth 1996; O’Farrell 2001; Ferrell
et al. 2009; Lindqvist et al. 2009; Santos et al. 2012; Fig. 4b).
The initial activation of cyclin B-Cdk1 may roughly (but not
precisely) correlate with production of the primary MPF and
the autoregulatory activation of cyclin B-Cdk1 with the MPF
amplification.
Initial activation of cyclin B-Cdk1
Logically, prior to starting the autoactivation loop, a small
amount of cyclin B-Cdk1 should be activated by the cyclin
B-Cdk1-independent, putative initial activator (Fig. 4b). It re-
mains unclear in vivo in most higher eukaryotic somatic cells
what molecule(s) is(are) the actual initial activator(s) of cyclin
B-Cdk1, although Aurora A, Plk1, cyclin A-Cdk1/2, and
Cdc25B might all be involved in tipping the balance between
Wee1/Myt1 and Cdc25 (for reviews, see Nigg 2001; O’Farrell
2001; Lindqvist et al. 2009). Some investigators regard the
initial activation to be the result of redundant or stochastic
processes involving these molecules (O’Farrell 2001;
Lindqvist et al. 2009).
In contrast, the starfish oocyte represents an exceptional
system in which the initial activator is well characterized
(Fig. 5a). Akt/PKB, which is activated downstream of the
starfish maturation-inducing hormone (1-methyladenine, 1-
MeAde; Kanatani et al. 1969) with no requirement of new
protein synthesis, clearly functions as an in vivo initial activa-
tor (Okumura et al. 2002). Akt/PKB directly phosphorylates
both Cdc25 andMyt1 to reverse the balance of their activities,
resulting in net removal of inhibitory phosphorylations on
Cdk1 (for reviews, see Kishimoto 2003, 2011). As in most
animal species, Wee1 is absent from immature oocytes of
starfish (Okano-Uchida et al. 2003); furthermore, activation
of Aurora (Abe et al. 2010) and Plk1 (Okano-Uchida et al.
2003) and new synthesis of cyclin A and Mos (Tachibana
et al. 2000) are absolutely downstream of, and not required
for, cyclin B-Cdk1 activation in starfish.
In Xenopus oocytes, progesterone downregulates cAMP-
dependent protein kinase A (PKA). Downstream of PKA in-
activation, new protein synthesis either of Mos or cyclin B is
required to trigger the initial activation of pre-existing cyclin
B-Cdk1 through the removal of the inhibitory phosphoryla-
tion on Cdk1 (Haccard and Jessus 2006a). However, the bio-
chemical steps that link PKA downregulation to the protein
synthesis of these intermediaries remain unclear (Haccard and
Jessus 2006b).
Autoregulatory activation of cyclin B-Cdk1
Core elements of the autoregulatory loop are cyclin B-Cdk1-
dependent phosphorylation both of Cdc25 for further activa-
tion and of Myt1/Wee1 for further inactivation. Although
many of the phosphorylations of Cdc25 and Myt1/Wee1 re-
sponsible for the positive feedback are directly catalyzed by
cyclin B-Cdk1 (O’Farrell 2001; Lindqvist et al. 2009), the
autoregulatory loop is not so simple because it also includes
antagonizing action against the protein phosphatase that coun-
teracts phosphorylations by cyclin B-Cdk1 (Fig. 5b).
Emerging studies indicate thatM phase is controlled by highly
coordinated activities between multiple protein kinases and
opposing protein phosphatases (for reviews, see Lindqvist
et al. 2009; Mochida and Hunt 2012; Qian et al. 2013).
Typical ly, many of the cyclin B-Cdk1-catalyzed
Fig. 4 Two-step activation of MPF and cyclin B-Cdk1. a Initial
activation and amplification of MPF. Initiator activates a small amount
of preMPF toMPF (initial activation), and thereafter, MPF itself activates
large amounts of preMPF to MPF (amplification). b Initial activation and
autoregulatory activation of cyclin B-Cdk1. At the initial onset of the G2/
M phase transition, a putative initial activator reverses the balance be-
tween Cdc25 and Myt1/Wee1 to trigger activation of a small amount of
cyclin B-Cdk1 (initial activation), and thereafter, the active cyclin B-
Cdk1 starts the autoactivation loop to induce activation of large amounts
of cyclin B-Cdk1 (autoregulatory activation)
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phosphorylations of Cdc25 and Myt1/Wee1 are in large part
opposed by heterotrimeric PP2A that contains a regulatory
subunit of the B55 family (PP2A-B55; Mochida et al. 2009).
Accordingly, a key issue in understanding the autoregulatory
activation is how cyclin B-Cdk1 turns off PP2A-B55.
Mutations in the gene encoding Greatwall kinase (Gwl) in
the fruit fly Drosophila were first identified as a dominant
allele called Scott of the Antarctic (Scant; White-Cooper
et al. 1996) and as recessive alleles called greatwall (gwl; Yu
et al. 2004). Gwl itself was originally described as a nuclear
protein required for proper chromosome condensation and M
phase progression (Yu et al. 2004; Archambault et al. 2007).
Further studies in frog Xenopus eggs and their extracts re-
vealed several points that are illustrated in Fig. 5b. (1)
Cyclin B-Cdk1 is important for Gwl activation (Yu et al.
2006; Vigneron et al. 2011; Blake-Hodek et al. 2012). (2)
Gwl participates in the autoactivation loop of cyclin B-Cdk1
(Yu et al. 2006). (3) This action of Gwl in the autoactivation
loop includes negative regulation of PP2A-B55 (Zhao et al.
2008; Vigneron et al. 2009; Castilho et al. 2009). (4) This
suppression is accomplished through direct phosphorylation
by Gwl of Ensa/Arpp19 (Ensa, α-endosulfine; and its close
relative Arpp19, cyclic adenosine monophosphate-regulated
phosphoprotein 19) that, in turn, leads to inhibition of
PP2A-B55 (Gharbi-Ayachi et al. 2010; Mochida et al.
2010). (5) The phosphorylation and activation of Ensa/
Arpp19 by Gwl are opposed by PP2A-B55 (Williams et al.
2014). At least in the frog egg system, the cyclin B-Cdk1-
Gwl-Ensa/Arpp19 pathway is critical for suppressing PP2A-
B55 that counteracts cyclin B-Cdk1 (Fig. 5b). In this way,
cyclin B-Cdk1-driven phosphorylations of Cdc25 and Myt1/
Wee1 can be maintained to promote the autoregulatory acti-
vation of cyclin B-Cdk1.
In mammalian somatic cells, however, Gwl/MASTL (the
mammalian ortholog of Gwl) is largely dispensable for entry
into M phase, though it is essential for M phase progression
(Burgess et al . 2010; Voets and Wolthuis 2010;
Alvarez-Fernandez et al. 2013; Cundell et al. 2013).
Gwl-null cells enter into M phase with normal kinetics; after
NEBD, they display features of mitotic collapse such as de-
fective condensation and segregation of chromosomes,
prometaphase arrest, and disordered cytokinesis. The fact that
such cells can enter M phase suggests a possible
autoregulatory activation of cyclin B-Cdk1 in the absence of
P P P P
Fig. 5 Pathways leading to initial
activation and autoregulatory
activation of cyclin B-Cdk1. a
Pathway toward the initial
activation of cyclin B-Cdk1 in
starfish oocytes. A putative re-
ceptor of maturation-inducing
hormone (1-MeAde) is localized
on the oocyte surface. Down-
stream of this signal, Akt/PKB is
activated and then directly phos-
phorylates both Cdc25 and Myt1
to reverse their activity balance,
triggering activation of cyclin B-
Cdk1. Akt/PKB thus clearly
functions as the initial activator. b
The cyclin B-Cdk1 autoactivation
loop. A key element is Arpp19/
Ensa-dependent inhibition of
PP2A-B55, which counteracts
phosphorylations of Cdc25 and
Myt1/Wee1 by cyclin B-Cdk1.
Activation of Arpp19/Ensa is ac-
complished through phosphory-
lation either by cyclin B-Cdk1 it-
self or by Gwl that is activated
downstream of cyclin B-Cdk1
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Gwl, although the degree of activation may be suboptimal.
Among invertebrates, the nematode Caenorhabditis elegans
has no obvious Gwl in its genome (Kim et al. 2012), whereas
cyclin B-Cdk1 is believed to function as in other eukaryotic
cells. Most strikingly, although the starfish oocyte indeed has
Gwl that is exclusively present in the germinal vesicle (GV;
i.e., the oocyte nucleus), cyclin B-Cdk1 can be nonetheless
fully activated both in enucleated oocytes that lack Gwl and in
nucleated oocytes in which Gwl activity is suppressed by an-
tibody injection (Hara et al. 2012; see Fig. 2a, b). All of these
facts support the idea that the autoregulatory activation of
cyclin B-Cdk1 can be accomplished even in the absence of
Gwl.
How is it possible that cyclin B-Cdk1 can be activated if
Gwl is not present? The probable answer involves two facts
which were found in the starfish oocyte system (Okumura
et al. 2014). First, what is essential for the autoactivation loop
is not Gwl but is instead the downstream Arpp19 (and most
likely Ensa); and second, cyclin B-Cdk1 directly phosphory-
lates Arpp19 on a conserved site (Ser69) different from that
targeted by Gwl, resulting in inhibition of PP2A-B55.
Although Arpp19 phosphorylated by cyclin B-Cdk1 alone is
significantly less effective in inhibiting PP2A-B55 than
Arpp19 phosphorylated by cyclin B-Cdk1 plus Gwl, a partial
reduction of PP2A-B55 activity by the cyclin B-Cdk1-Arpp19
bypass is most likely sufficient for the autoregulatory activa-
tion of cyclin B-Cdk1 (Fig. 5b).
The homologous site for Ser69 of starfish Arpp19 is pres-
ent in human Arpp19 on Ser23, on Ser28 of frog Arpp19, on
Thr28 of frog Ensa, and on Ser21 of C. elegans Ensa
(Okumura et al. 2014). This site is not present in human
Ensa or in the single Ensa family member in Drosophila,
although, in fruit flies, the equivalent position is a
phosphomimetic aspartic acid (Kim et al. 2012). Given that
the homologous site is present in both frog Ensa and frog
Arpp19, it is somewhat puzzling why Gwl is essential for
cyclin B-Cdk1 activation in cycling extracts from frog eggs
(Yu et al. 2006). Possible explanations for the frog case might
involve the unusual cytoplasmic localization of Gwl in frog
oocytes (Hara et al. 2012) and/or the use of self-oscillatory egg
extracts whose autoregulation may vary slightly from that
seen in vivo. Taken together, certainly in several systems, it
appears that direct phosphorylation by cyclin B-Cdk1 or a
phosphomimetic mutation of at least one Arpp19/Ensa family
member is sufficient for at least a partial autoregulatory acti-
vation of cyclin B-Cdk1.
These many observations can be rationalized by a simple
model. In normal cells containing Gwl, the cyclin B-Cdk1-
Arpp19/Ensa bypass might start the autoactivation loop im-
mediately after the initial activation of cyclin B-Cdk1.
Subsequently, after cyclin B-Cdk1 activates Gwl, both the
cyclin B-Cdk1-Arpp19/Ensa bypass and the cyclin B-Cdk1-
Gwl-Arpp19/Ensa pathway would act synergistically to
accomplish the swift and robust autoactivation of cyclin B-
Cdk1 (Fig. 5b).
MPF needs to antagonize the reactions that oppose cyclin
B-Cdk1
At the G2/M phase border, activation of cyclin B-Cdk1 is
strictly prevented by Myt1/Wee1 and PP2A-B55, while acti-
vation of Cdc25 coupled with inactivation of Myt1/Wee1 en-
sure the swift and robust activation of cyclin B-Cdk1 at entry
into M phase. Under physiological conditions, both Cdc25
activation and Myt1/Wee1 inactivation are accomplished first
by the initial activator and, subsequently, via the
autoregulatory loop (see above; Fig. 4b), implying that the
autoregulatory activation of cyclin B-Cdk1 is initiated after
the balance between Myt1/Wee1 and Cdc25 has been first
reversed by the initial activator (see Fig. 3 in Okumura et al.
1996; Fig. 1 in Okumura et al. 2002). But in the microinjection
assay, MPF from the donor oocyte is forced to initiate the
autoregulatory activation of cyclin B-Cdk1 in the recipient
oocyte without the aid of the initial activator and thus in the
complete absence of both Cdc25 activation and Myt1/Wee1
inactivation. This fact implies that the active cyclin B-Cdk1
contained in donor MPF would be opposed by two major
reactions in recipient cells. First, the introduced cyclin B-
Cdk1 would be directly attacked by Myt1/Wee1. Second,
even if this cyclin B-Cdk1 could survive this first attack, its
ability to start the cyclin B-Cdk1 autoactivation loop would
then be opposed by PP2A-B55.
These two opposing reactions against the active donor cy-
clin B-Cdk1 that is introduced into G2 phase cells could ex-
plain whyMPF requires the nuclear factor in addition to cyclin
B-Cdk1 in starfish; that is, the nuclear factor might antagonize
the opposing reactions through supporting the autoregulatory
activation of cyclin B-Cdk1. Intriguingly, Picard et al. (1991)
found that okadaic acid, a potent inhibitor of PP2A, potenti-
ates the ability of a low, physiological level of purified cyclin
B-Cdk1 to induce the G2/M phase transition in the microin-
jection assay (i.e., this level of cyclin B-Cdk1 is insufficient to
induce the transition if okadaic acid is not present) . If this
potentiation is executed through the autoregulatory activation
of cyclin B-Cdk1, PP2A inhibition could be involved in MPF
amplification. Based on these considerations, the authors pro-
posed that the nuclear factor might be a PP2A inhibitor which
acts synergistically with cyclin B-Cdk1 to induce MPF
amplification.
These findings, taken together with recent knowledge
about the suppression of PP2A-B55 activity during M phase,
suggest the plausible hypothesis that the nuclear factor re-
quired for MPF could be a component of the pathway that
leads to activation of Arpp19/Ensa for PP2A inhibition.
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The enigma’s solution: Gwl and cyclin B-Cdk1 together
constitute MPF
Which component of the cyclin B-Cdk1-Gwl-Arpp19/Ensa
pathway or the cyclin B-Cdk1-Arpp19/Ensa bypass
(Fig. 5b) is localized exclusively in the nucleus? Cyclin B-
Cdk1 is localized in the cytoplasm at the G2/M phase border
(Pines and Hunter 1991b; Ookata et al. 1992), and PP2A-B55
is largely cytoplasmic (Mayer-Jaekel et al. 1994; Santos et al.
2012; Alvares-Fernandez et al. 2013). Ensa is present in both
the cytoplasm and the nucleus in the fruit fly (Rangone et al.
2011), while Arpp19 is largely cytoplasmic in starfish oocytes
(Okumura et al. 2014), excluding these molecules as candi-
dates for the nuclear factor. In contrast, Gwl was originally
described as a nuclear protein (Yu et al. 2004; see also Wang
et al. 2013), supporting Gwl as the most likely candidate for
the nuclear factor.
Gwl is indeed localized exclusively in the nucleus (GV) in
immature starfish oocytes as well, and it is activated immedi-
ately after, and downstream of, the activation of cyclin B-
Cdk1 during the G2/M phase transition (Hara et al. 2012).
When Gwl activity is suppressed through antibody injection,
MPF is undetectable even from nucleated oocytes in which
cyclin B-Cdk1 is fully activated. Conversely, MPF is restored
when Gwl is added back to enucleated donor oocytes or when
Gwl is supplemented to the cytoplasm obtained from enucle-
ated donor oocytes (Fig. 2b), whereas Gwl alone fails to ex-
hibit MPF function even when added at seven-fold excess of
the physiological amounts. Furthermore, addition of recombi-
nant Gwl to purified cyclin B-Cdk1 greatly reduces the
amount of cyclin B-Cdk1 required for the microinjection as-
say of MPF (Fig. 2d). This great reduction is the case in
Xenopus oocytes as well. Although cyclin B-Cdk1 alone can
induce NEBD when injected at ten-fold excess the
physiological amounts, spindle assembly thereafter is abor-
tive; in contrast, when accompanied by Gwl, normal amounts
of cyclin B-Cdk1 lead to formation of apparently normal spin-
dles. These results allow us to conclude that Gwl itself is the
essential nuclear factor required for MPF (Hara et al. 2012;
Fig. 6).
Although Gwl was identified as an essential component of
classically defined MPF in the oocyte, one specialized type of
germline cell, Gwl may be a critical constituent of MPF in the
somatic cells of higher eukaryotes as well, because Gwl/
MASTL is also nuclear in human somatic cells (Burgess
et al. 2010; Alvarez-Fernandez et al. 2013) and in
Drosophila cells (Yu et al. 2004; Wang et al. 2013). This
supposition might explain why the literature has no reports
that the simple introduction of active cyclin B-Cdk1 causes
G2/M phase transition in somatic cells (Hagting et al. 1998;
Fung et al. 2007).
Given that Arpp19/Ensa can be directly activated by cyclin
B-Cdk1 in the bypass pathway (Okumura et al. 2014), Arpp19
should be active in hormone-treated enucleated starfish oo-
cytes, but MPF is undetectable from these oocytes
(Kishimoto et al. 1981; Picard and Doree 1984). Why can’t
the cyclin B-Cdk1-activated Arpp19/Ensa replace Gwl as a
component of MPF? According to the recent Bunfair compe-
tition model^ proposed by Williams et al. (2014), the Gwl
phosphorylation of Arpp19/Ensa is reversed by PP2A-B55
itself. In contrast, the cyclin B-Cdk1-mediated phosphoryla-
tion of Arpp19/Ensa is very hard to remove at M phase exit
and is reversed by unknown, okadaic acid-insensitive phos-
phatase other than PP2A-B55 (Williams and Goldberg, per-
sonal communication; see also Fig. S3 in Cundell et al. 2013
and Fig. 1 in Mochida 2014). It is thus less likely that the
active, cyclin B-Cdk1-phosphorylated form of Arpp19/Ensa
is rapidly dephosphorylated and inactivated by phosphatases
P P P P
Fig. 6 MPF and cyclin B-Cdk1 activation. In vivo, cyclin B-Cdk1 acti-
vation is accomplished via the initial activation step and the following
autoregulatory activation step. In contrast, MPF, which is introduced into
recipient cells, skips the initial activation step and is forced to start the
autoactivation loop to accomplish the activation of cyclin B-Cdk1. In the
absence of the initial activation step, the balance in the cell of Cdc25 and
Myt1/Wee1 activities is weighted toward the inactivation of cyclin B-
Cdk1. This is the reason why a physiological level of cyclin B-Cdk1
alone is insufficient for MPF and why Gwl is further required for MPF.
Based on the classical microinjection assay, MPF thus consists of both
cyclin B-Cdk1 and Gwl
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in the recipient oocytes. Instead, it should be remembered that
Arpp19/Ensa phosphorylated by cyclin B-Cdk1 is less effi-
cient in suppressing PP2A-B55 than are the same proteins
phosphorylated by Gwl (Mochida 2014; Okumura et al.
2014); and further that the active Arpp19/Ensa is diluted ap-
proximately 15-fold after microinjection into the recipient oo-
cytes (see Fig. 3 legend). These may make the introduced
Arpp19/Ensa inefficient to inhibit PP2A-B55 in the recipient
oocytes. In short, the cyclin B-Cdk1-phosphorylated form of
Arpp19/Ensa alone is insufficient: The coexistence of active
Gwl kinase is needed to maintain the suppression of PP2A-
B55 so as to start the autoactivation loop for cyclin B-Cdk1 in
recipient cells.
Based on its classical definition through microinjection as-
say, MPF is thus not synonymous with cyclin B-Cdk1, but
instead, MPF is composed of both cyclin B-Cdk1 and Gwl.
In other words, MPF is a system consisting of both cyclin B-
Cdk1 that directs mitotic entry and Gwl that suppresses the
anti-cyclin B-Cdk1 phosphatase, PP2A-B55.
Other historical riddles about MPF
Why is MPF detectable from enucleated frog oocytes?
It is well known that enucleation does not prevent the appear-
ance of MPF in oocytes of the frog species R. pipiens (Masui
and Markert 1971) and X. laevis (Iwashita et al. 1998). Recall
that immature frog oocytes are exceptional in that Gwl is
mostly localized in their cytoplasm (Hara et al. 2012). This
localization explains why MPF is detectable from enucleated
Xenopus oocytes that would contain both active cyclin B-
Cdk1 and active Gwl. Even so, evidence exists that in the
Xenopus oocyte system as well, Gwl contributes to MPF
through reducing the required amount of cyclin B-Cdk1
(Hara et al. 2012), suggesting that the contribution of Gwl to
MPF is most likely a general feature regardless of Gwl’s in-
tracellular localization. A plausible explanation for the biolog-
ical implications of species differences in the nuclear versus
cytoplasmic localization of Gwl would be that the unusually
large cytoplasmic volume of the frog oocyte may make nucle-
ar localized Gwl inadequate to support the swift and robust
autoactivation of cyclin B-Cdk1.
Timing of MPF detection in oocytes
In its original definitions, MPF was regarded to be a cytoplas-
mic activity that controls the nucleus (Masui and Markert
1971) or that mediates transfer of the maturation-inducing
hormonal stimulus from the oocyte surface to the nucleus
(Kishimoto and Kanatani 1976). If so, in the classical micro-
injection assay, MPF should be principally detectable within
the cytoplasm of donor oocytes prior to NEBD. MPF in Rana
oocytes behaves exactly in this way (Masui and Markert
1971), and we can now explain this fact by the cytoplasmic
localization of Gwl in frog oocytes (Hara et al. 2012). In
contrast, starfish MPF is very hard to detect until just before
the occurrence of NEBD (Kishimoto and Kanatani 1976),
despite the facts that cyclin B-Cdk1 is already almost fully
activated before NEBD (Ookata et al. 1992) and that Gwl is
fully activated very soon after cyclin B-Cdk1 activation (Hara
et al. 2012). Instead, prior to NEBD in hormone-treated oo-
cytes, MPF is occasionally detectable in the nucleus but not in
the cytoplasm (Picard and Doree 1984; Picard et al. 1991).
Although these observations have long been puzzling, we
can now understand why MPF from starfish behaves as it
does. First, after it is activated in the cytoplasm, cyclin B-
Cdk1 is transported into the nucleus and accumulates there
(Ookata et al. 1992). Second, Gwl is exclusively localized in
the nucleus until just before NEBD (Hara et al. 2012), so Gwl
activation most likely occurs in the nucleus only after active
cyclin B-Cdk1 has been imported. Third, Gwl is likely to be
exported from the nucleus to the cytoplasm just before NEBD,
as has recently been shown in somatic cells (Wang et al. 2013;
Alvarez-Fernandez et al. 2013). These points account for the
previously confusing behavior of MPF in starfish, explaining
both why MPF detection in starfish oocytes is easier after
NEBD than before NEBD, and why MPF is detectable in
the nucleus but not in the cytoplasm before NEBD.
Concluding remarks: reconciling MPF, Gwl, and cyclin
B-Cdk1
After four decades, it is now finally clear that according to the
classical microinjection assay, MPF consists not only of cyclin
B-Cdk1 but also of Gwl. It required 20 years for the identifi-
cation of cyclin B-Cdk1 and another 20 years for the identifi-
cation of Gwl. Unfortunately, however, a major gap now ex-
ists between the relatively imprecise way in which the current
literature uses the term BMPF^ as a synonym for cyclin B-
Cdk1 and the original functional definition of MPF, which
now must encompass Gwl as well.
How can this gap be reconciled? The reason this gap exists
involves two features of the classical MPF assayed functionally
by microinjection: This MPF activity is transferable, and it can
be amplified. All of the components of MPF are derived from
donor cells, but the presence of classical MPF can be verified
only by its activity in recipient cells. In contrast, when re-
searchers use the term MPF today as a synonym for cyclin B-
Cdk1 (Bcurrent MPF^ below), they are describing an activity
that exists in donor cells and is verified biochemically as M
phase-specific histone H1 kinase. In vivo in donor cells, the
activation of cyclin B-Cdk1 requires that the balance between
Cdc25 and Myt1/Wee1 must first be tipped by the initial acti-
vator, and thereafter, the small resultant amount of active cyclin
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B-Cdk1 starts its autoactivation loop (Fig. 6). In contrast, when
the classical MPF is transferred and induces the G2/M phase
transition in recipient cells, the introduced active cyclin B-Cdk1
must start its autoactivation loop under circumstances in which
the initial activator-dependent reversal of the balance between
Cdc25 and Myt1/Wee1 has not yet been accomplished. This
skipping of the initial activator-dependent step explains why
classically defined MPF requires Gwl in addition to cyclin B-
Cdk1. In other words, when the initial activation step is already
accomplished, a low level of cyclin B-Cdk1 alone is sufficient
to drive the autoactivation loop (a situation seen in the current
MPF); but when the initial activation step is bypassed, the
autoactivation loop requires either the addition of Gwl to low
levels of cyclin B-Cdk1 (reconstituting the classical MPF) or an
extraordinarily high activity level of purified cyclin B-Cdk1
alone (Okumura et al. 1996; Hara et al. 2012).
The gap between the classical MPF and the current MPF
thus reflects differences in the assay systems employed and
quantification of cyclin B-Cdk1 activity. Considering that
MPF was originally identified as the cytoplasmic activity, it
is misleading to suggest that there is one universal MPF mol-
ecule(s). Instead, MPF is most accurately regarded as a path-
way whose specifics depend on the experimental system being
investigated. In other words, we should now understand that
MPF in its most fundamental sense is not only cyclin B-Cdk1,
but is instead a complex network involved in the
autoregulatory activation of cyclin B-Cdk1.
The finding that cyclin B-Cdk1 phosphorylation of
Arpp19/Ensa is sufficient to drive the cyclin B-Cdk1
autoactivation loop in the absence of Gwl (Okumura et al.
2014) raises the question: What essential role does Gwl play?
In fact, in many systems including human somatic cells, Gwl
exhibits more impact after NEBD: Gwl is nonessential for
mitotic entry, but it is necessary for further mitotic progression
including events such as chromosome condensation (Alvarez-
Fernandez et al. 2013), the proper segregation of chromo-
somes (Okumura et al. 2014), and orderly cytokinesis follow-
ing chromosome separation (Cundell et al. 2013). One intrigu-
ing possibility would be that Gwl regulates these post-NEBD
events by phosphorylating other currently unknown substrates
besides Arpp19/Ensa. An alternative possibility is that
Arpp19/Ensa inhibits PP2A-B55 in a biphasic manner
(Okumura et al. 2014). That is, more potent Arpp19/Ensa
phosphorylated by both cyclin B-Cdk1 and Gwl might be
necessary for these events that occur after cyclin B-Cdk1 ac-
tivation, whereas less potent Arp19/Ensa phosphorylated by
cyclin B-Cdk1 alone is sufficient for cyclin B-Cdk1
autoactivation, but is not sufficient for these later events. A
plausible basis for this hypothesis is that various phosphopro-
tein substrates have different sensitivities to various levels of
PP2A-B55 phosphatase activity: It will therefore be intriguing
to identify the substrates that exhibit greater or lesser sensitiv-
ities to the inhibition of PP2A-B55.
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